South Korea
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 749.42 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
2 |
USD 335.58 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
3 |
USD 141.32 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
4 |
USD 86.66 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
5 |
USD 71.79 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
6 |
USD 46.47 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
7 |
USD 19.58 M
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
8 |
USD 10.99 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
9 |
USD 8.24 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
10 |
USD 6.85 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
11 |
USD 5.09 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
12 |
USD 4.52 M
|
Dec. 31, 2023 | USD 8.83 | 4.03% |
|
South Korea |
|
13 |
USD 2.73 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
14 |
USD 2.53 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
15 |
USD 1.54 M
|
Dec. 31, 2023 | USD 4.40 | -2.27% |
|
South Korea |
|
16 |
USD 1.53 M
|
Dec. 31, 2023 | USD 3.75 | -3.31% |
|
South Korea |
|
17 |
USD 771.90 K
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
18 |
USD 111.09 K
|
Dec. 31, 2023 | USD 1.65 | -4.10% |
|
South Korea |
|
19 |
USD 0.29
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
|
20 |
USD 0.27
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
21 |
USD 0.00
|
Dec. 31, 2023 | USD 3.29 | -3.64% |
|
South Korea |
The Vaccines company in South Korea with the highest Receivables is Celltrion, Inc. (KSE: 068270.KS) at USD 749.42 M.
The Vaccines company in South Korea with the lowest Receivables is Cellid, Co., Ltd. (KOSDAQ: 299660.KQ) at USD 0.00.
The top 10 Vaccines companies in South Korea by Receivables are Celltrion, Inc., Green Cross Corporation, Daewoong pharmaceutical Co.,Ltd, Dong-A Socio Holdings Co., Ltd., Seegene, Inc., Medy-Tox Inc., Green Cross Holdings Corporation, ALTEOGEN Inc., Genexine, Inc. and SK bioscience Co.,Ltd..
The bottom 10 Vaccines companies in South Korea by Receivables are Cellid, Co., Ltd., Samjin Pharmaceuticals Co., Ltd., MedPacto, Inc., SillaJen, Inc., Gencurix Inc., iNtRON Biotechnology, Inc., Sugentech Inc., CrystalGenomics, Inc., OliX Pharmaceuticals,Inc and EuBiologics Co., Ltd..